Pre-treatment prostate MRI predicts recurrence and survival after surgery. Discover how imaging improves risk assessment.
MedPage Today on MSN
MRI before treatment could provide prognostic information in prostate cancer
Meta-analysis shows several MRI-derived parameters were associated with outcomes ...
For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...
To evaluate changes in PI-RADS ≥ 3 lesions on prostate MRI after prostate artery embolization (PAE) performed for lower urinary tract symptoms. This retrospective single-center study included 18 ...
When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...
ARTIFICIAL intelligence (AI) integrated with magnetic resonance imaging (MRI) significantly improved biopsy decision-making in prostate cancer diagnosis, according to new research presented at the ...
Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...
Alam frames PHI and MRI as noninvasive tools that help refine risk before proceeding to biopsy. In this video, Ridwan I. Alam, MD, MPH, discusses how the Prostate Health Index (PHI) performs alongside ...
The BIOPSTAGE trial investigates the added diagnostic value of combining prostate-specific membrane antigen positron emission tomography (PSMA PET) with multiparametric MRI (mpMRI) for non-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results